AU1068101A - Transdermal administration of reboxetine - Google Patents

Transdermal administration of reboxetine

Info

Publication number
AU1068101A
AU1068101A AU10681/01A AU1068101A AU1068101A AU 1068101 A AU1068101 A AU 1068101A AU 10681/01 A AU10681/01 A AU 10681/01A AU 1068101 A AU1068101 A AU 1068101A AU 1068101 A AU1068101 A AU 1068101A
Authority
AU
Australia
Prior art keywords
reboxetine
transdermal administration
transdermal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10681/01A
Inventor
Ulla Hoeck
Bo Kreilgard
Helle Kristensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of AU1068101A publication Critical patent/AU1068101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU10681/01A 1999-12-23 2000-10-12 Transdermal administration of reboxetine Abandoned AU1068101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904750 1999-12-23
SE9904750A SE9904750D0 (en) 1999-12-23 1999-12-23 New formulation, use and method
PCT/SE2000/001972 WO2001047503A1 (en) 1999-12-23 2000-10-12 Transdermal administration of reboxetine

Publications (1)

Publication Number Publication Date
AU1068101A true AU1068101A (en) 2001-07-09

Family

ID=20418276

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10681/01A Abandoned AU1068101A (en) 1999-12-23 2000-10-12 Transdermal administration of reboxetine

Country Status (7)

Country Link
EP (1) EP1244431A1 (en)
AR (1) AR026371A1 (en)
AU (1) AU1068101A (en)
MY (1) MY133485A (en)
PE (1) PE20011024A1 (en)
SE (1) SE9904750D0 (en)
WO (1) WO2001047503A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1629843A3 (en) * 1999-07-01 2006-03-15 Pharmacia & Upjohn Company LLC Reboxetine for treating chronic fatigue syndrome
ATE305307T1 (en) 1999-07-01 2005-10-15 Pharmacia & Upjohn Co Llc REBOXETINE FOR THE TREATMENT OF MIGRAINE HEADACHE
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
TWI754702B (en) 2016-12-28 2022-02-11 德商Ｕｃｂ製藥有限公司 (aza)indole- and benzofuran-3-sulfonamides
DE102017127433A1 (en) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS based on adhesive plasticizer polymer matrices
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
TW202016088A (en) 2018-06-19 2020-05-01 德商Ｕｃｂ製藥有限公司 Pyridinyl and pyrazinyl-(aza)indolsulfonamides
EP3584244A1 (en) 2018-06-20 2019-12-25 UCB Pharma GmbH Substituted alkoxypyridinyl indolsulfonamides
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
ES2969383T3 (en) 2019-06-17 2024-05-17 Ucb Pharma Gmbh N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as modulators of GPR17 for the treatment of CNS disorders such as multiple sclerosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011208A1 (en) * 1997-08-28 1999-03-11 Williams C Donald Method and composition for transdermal administration of pharmacologic agents

Also Published As

Publication number Publication date
PE20011024A1 (en) 2001-10-03
AR026371A1 (en) 2003-02-05
WO2001047503A1 (en) 2001-07-05
EP1244431A1 (en) 2002-10-02
MY133485A (en) 2007-11-30
SE9904750D0 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
AU1585601A (en) Transdermal administration of huperzine
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
AU5259100A (en) Medicament
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU1887401A (en) Medicinal composition
AU2208401A (en) Inhibitors of complement activation, their preparation and use
AU7377200A (en) Combination therapy including camptothecin
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
AU1068101A (en) Transdermal administration of reboxetine
AU3869399A (en) Transdermal administration of fenoldopam
AU5460800A (en) Pharmaceutical transdermal compositions
AU2001243515A1 (en) Combination drug therapy
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU2451500A (en) Therapeutic agents
AU2982000A (en) Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU5765700A (en) Preparation of a therapeutic composition
AU6846500A (en) Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU3760900A (en) Treatment of menstrual function
AU5973600A (en) Therapeutic agents
AU3971800A (en) 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
AU6106801A (en) Trans-clitoral administration of therapy
AU6150200A (en) Therapeutic agents
AU4504201A (en) Drug preparations
AU5139800A (en) Topical administration of ketotifen

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase